BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
bandaram pharma packtech limit stock

BANDARAM PHARMA PACKTECH LIMIT Share Price

44 -0.50 (-1.12%)
Dec 13 2024 03:29 PM Healthcare NSE: BANDARAM

BANDARAM PHARMA PACKTECH LIMIT Share Price Update

As of the latest trading session, BANDARAM PHARMA PACKTECH LIMIT share price is currently at 44, which is down by -0.50 from its previous closing. Today, the stock has fluctuated between 42.29 and 44.60. Over the past year, BANDARAM PHARMA PACKTECH LIMIT has achieved a return of 42.42 %. In the last month alone, the return has been -0.88 %. Read More...

BANDARAM PHARMA PACKTECH LIMIT Performance

Day Range

Low42.29 High44.60
43.71

52 Week Range

Low 28.31 High 63.14
43.71

BANDARAM PHARMA PACKTECH LIMIT Share Price

524602

BANDARAM

img img img img
No Data Available

Open Price

44.60

Prev. Close

44.51

Volume (Shares)

1396.00

Total traded value

.60

Upper Circuit

46.73

Lower Circuit

42.29

Note: The current prices & values are delayed, Login to your account for live updates.

BANDARAM PHARMA PACKTECH LIMIT Fundamentals


(Standalone)

Market Cap (Cr) 52.80
PE Ratio (TTM) 437.10
Book Value / Share 10.23
Beta -0.04
ROE 1.70%
EPS (TTM) 0.10
Dividend Yield 0.23%
Net Profit Qtr (Cr) 0.33

BANDARAM PHARMA PACKTECH LIMIT Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 3.17
Operating Expense 2.84
Net Profit 0.33
Net Profit Margin (%) 10.41
Earnings Per Share (EPS) 0.28
EBITDA 0.33
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 2.72
Operating Expense 2.97
Net Profit -0.25
Net Profit Margin (%) -9.19
Earnings Per Share (EPS) -0.21
EBITDA -0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 1.50
Operating Expense 1.53
Net Profit -0.02
Net Profit Margin (%) -1.33
Earnings Per Share (EPS) -0.01
EBITDA -0.01
Effective Tax Rate (%) -100.00
Particulars DEC 2023 (Values in Cr)
Revenue 5.70
Operating Expense 5.64
Net Profit 0.05
Net Profit Margin (%) 0.87
Earnings Per Share (EPS) 0.04
EBITDA 0.07
Effective Tax Rate (%) 28.57
Particulars SEP 2023 (Values in Cr)
Revenue 3.54
Operating Expense 3.49
Net Profit 0.05
Net Profit Margin (%) 1.41
Earnings Per Share (EPS) 0.05
EBITDA 0.05
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 14.84
Operating Expense 14.69
Net Profit 0.13
Net Profit Margin (%) 0.87
Earnings Per Share (EPS) 0.11
EBITDA 0.19
Effective Tax Rate (%) 23.52
Particulars MAR 2023 (Values in Cr)
Revenue 10.09
Operating Expense 9.82
Net Profit 0.20
Net Profit Margin (%) 1.98
Earnings Per Share (EPS) 0.68
EBITDA 0.27
Effective Tax Rate (%) 25.92
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.01
Net Profit -0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.03
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2018 (Values in Cr)
Revenue 0.00
Operating Expense 1.15
Net Profit -1.16
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -5.10
EBITDA -1.13
Effective Tax Rate (%) 0.00
Particulars MAR 2017 (Values in Cr)
Revenue 0.00
Operating Expense 1.12
Net Profit -1.09
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -4.79
EBITDA -1.06
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 10.23
ROE % 12.37
ROCE % 10.15
Total Debt to Total Equity 1.72
EBITDA Margin 8.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.28
ROE % 8.44
ROCE % 4.40
Total Debt to Total Equity 4.61
EBITDA Margin 7.15
Particulars MAR 2024 (Values in Cr)
Book Value / Share 10.17
ROE % 1.70
ROCE % 1.73
Total Debt to Total Equity 0.29
EBITDA Margin 1.28
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.25
ROE % 6.60
ROCE % 5.16
Total Debt to Total Equity 0.73
EBITDA Margin 2.68
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.97
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.17
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -10.18
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2018 (Values in Cr)
Book Value / Share -7.82
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 32.05
Total Liabilities 32.05
Total Equity 15.06
Share Outstanding 12000000
Price to Book Ratio 3.64
Return on Assets (%) 1.62
Return on Capital (%) 1.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 20.17
Total Liabilities 20.17
Total Equity 5.13
Share Outstanding 3000000
Price to Book Ratio 7.12
Return on Assets (%) 0.70
Return on Capital (%) 0.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 13.35
Total Liabilities 13.35
Total Equity 12.20
Share Outstanding 12000000
Price to Book Ratio 3.64
Return on Assets (%) 0.96
Return on Capital (%) 1.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 8.26
Total Liabilities 8.26
Total Equity 3.07
Share Outstanding 3000000
Price to Book Ratio 7.12
Return on Assets (%) 2.46
Return on Capital (%) 2.73
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.08
Total Assets 2.99
Total Liabilities 2.99
Total Equity 2.98
Share Outstanding 3000000
Price to Book Ratio 0.00
Return on Assets (%) -0.33
Return on Capital (%) -0.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 1.26
Total Liabilities 1.26
Total Equity -2.31
Share Outstanding 2277000
Price to Book Ratio 0.00
Return on Assets (%) -2.50
Return on Capital (%) 3.65
Particulars MAR 2018 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 1.33
Total Liabilities 1.33
Total Equity -1.78
Share Outstanding 2277000
Price to Book Ratio -1.74
Return on Assets (%) -86.65
Return on Capital (%) 201.51
Particulars MAR 2024 (Values in Cr)
Net Income 1.18
Cash from Operations -3.91
Cash from Investing -1.57
Cash from Financing 5.59
Net change in Cash -0.11
Free Cash Flow -3.73
Particulars MAR 2023 (Values in Cr)
Net Income 0.32
Cash from Operations -1.09
Cash from Investing -5.30
Cash from Financing 4.46
Net change in Cash -1.93
Free Cash Flow 1.69
Particulars MAR 2024 (Values in Cr)
Net Income 0.17
Cash from Operations -3.18
Cash from Investing -1.40
Cash from Financing 4.61
Net change in Cash -0.01
Free Cash Flow -3.18
Particulars MAR 2023 (Values in Cr)
Net Income 0.27
Cash from Operations -3.86
Cash from Investing -2.53
Cash from Financing 4.40
Net change in Cash -1.99
Free Cash Flow -3.84
Particulars MAR 2022 (Values in Cr)
Net Income -0.01
Cash from Operations 2.91
Cash from Investing -1.55
Cash from Financing 0.72
Net change in Cash 2.08
Free Cash Flow 2.91
Particulars MAR 2021 (Values in Cr)
Net Income -0.03
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 88.28 13.93 104442.30 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 62.05 0.00 3.89 116.29 44.00 / 107.94
SHREE PACETRONIX LTD. 123.75 19.93 3.31 44.54 106.00 / 268.50
TRANSGENE BIOTEK LTD. 7.60 0.00 5.31 57.59 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 7263.80 93.01 12.75 104442.30 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 52.25 0.00 -27.99 39.03 29.25 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5501.45 29.84 6.18 6018.59 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 44.70
  • 26 Days 45.10
  • 10 Days 44.90
  • 50 Days 48.40
  • 12 Days 45.20
  • 100 Days 44.10
  • 20 Days 44.60
  • 200 Days 32.20
44.94
PIVOT
First Resistance 46.12
Second Resistance 47.73
Third Resistance 48.91
First Support 43.33
Second Support 42.15
Third Support 40.54
RSI 44.88
MACD 0.07
Commodity Channel Index (CCI) -41.04
ADX 11.13
Williams % R -69.92

Over 1 Month

down

-0.88

Over 3 Months

down

9.68

Over 6 Months

down

26.14

Over 1 Year

down

42.42

Over 3 Years

down

76.57

Over 5 Years

down

0.00

BANDARAM PHARMA PACKTECH LIMIT Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

BANDARAM PHARMA PACKTECH LIMIT Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
24.99
Promoter Holdings
75.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
B.deepak Reddy Shareholding of Promoter and Promoter Group 4725000.0 39.38
B.premsai Reddy Shareholding of Promoter and Promoter Group 1800000.0 15.0
B.sathyavathi Shareholding of Promoter and Promoter Group 1800000.0 15.0
Sanivarapu Jhansi Public Shareholding 785000.0 6.54
L. Lalanthika Shareholding of Promoter and Promoter Group 450000.0 3.75
Sanivarapu Navya Reddy Public Shareholding 414009.0 3.45
Sreedar Reddy G Public Shareholding 400000.0 3.33
Sapnaa Public Shareholding 300000.0 2.5
Suresh Kumar Surana Public Shareholding 157044.0 1.31
M. Sukumari Shareholding of Promoter and Promoter Group 112500.0 0.94
M. Seetharama Reddy Shareholding of Promoter and Promoter Group 112500.0 0.94

BANDARAM PHARMA PACKTECH LIMIT

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-22 0.1 Final 2023-09-23 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About BANDARAM PHARMA PACKTECH LIMIT

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by BANDARAM PHARMA PACKTECH LIMIT

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Bandaram Pharma Packtech Ltd?

Answer Field

The share price of Bandaram Pharma Packtech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 43.71.

What is the Market Cap of Bandaram Pharma Packtech Ltd?

Answer Field

The market cap of Bandaram Pharma Packtech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 52.50 Cr. as of now.

What is the 52 Week High and Low of Bandaram Pharma Packtech Ltd?

Answer Field

The 52 Week High and Low of Bandaram Pharma Packtech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 63.14 and ₹ 28.31.

How to Buy Bandaram Pharma Packtech Ltd share?

Answer Field

You can trade in Bandaram Pharma Packtech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Bandaram Pharma Packtech Ltd?

Answer Field

The 1 year returns on the stock has been 42.42%.

What is the Current Share Price of Bandaram Pharma Packtech Ltd?

Answer Field

Bandaram Pharma Packtech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 43.71 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Bandaram Pharma Packtech Ltd Share?

Answer Field

The market cap of Bandaram Pharma Packtech Ltd for NSE ₹ 0.0 & for BSE ₹ 52.50 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Bandaram Pharma Packtech Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Bandaram Pharma Packtech Ltd share is 437.10.

What is the PB ratio of Bandaram Pharma Packtech Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Bandaram Pharma Packtech Ltd share is 10.23.

How to Buy Bandaram Pharma Packtech Ltd Share?

Answer Field

You can trade in Bandaram Pharma Packtech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bandaram Pharma Packtech Ltd Share on Bajaj Broking App?

Answer Field

To buy Bandaram Pharma Packtech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bandaram Pharma Packtech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader